130
Participants
Start Date
September 30, 2025
Primary Completion Date
March 30, 2027
Study Completion Date
December 31, 2030
Tranexamic acid (TXA)
Marcan-Tranexamic Acid 500 mg oral tablet over-encapsulated to match the placebo. Sandoz-Tranexamic Acid 100 mg/mL solution for injection via intravenous (IV) added to a 100mL infusion bag of NaCl 0.9% and infused by slow intravenous injection over 20 minutes.
Placebo
Placebo 500 mg consisting of an identical capsule to over-encapsulated tranexamic acid oral tablet entirely filled with microcrystalline cellulose, and sealed. Placebo 100 mg/mL solution for injection via intravenous (IV) consisting of 0.9% sodium chloride (saline).
St. Michael's Hospital, Toronto
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
The Physicians' Services Incorporated Foundation
OTHER
Unity Health Toronto
OTHER